These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2556617)

  • 21. Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine.
    Tripathi A; Welch SP
    Eur J Pharmacol; 1995 May; 278(1):27-32. PubMed ID: 7664811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol.
    Jaw SP; Makimura M; Oh KW; Hoskins B; Ho IK
    Eur J Pharmacol; 1994 May; 257(1-2):153-60. PubMed ID: 8082697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
    Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
    Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quaternary naltrexone reveals the central mediation of conditional opioid analgesia.
    Calcagnetti DJ; Helmstetter FJ; Fanselow MS
    Pharmacol Biochem Behav; 1987 Jul; 27(3):529-31. PubMed ID: 2821555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection.
    Sasaki T; Arakawa K; Shimada K; Saito N
    Gen Comp Endocrinol; 2000 Jun; 118(3):365-72. PubMed ID: 10843787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical effects of intracerebroventricular low-dose opioid antagonists in SHR with chronic pain.
    Kolaric S; Makulska-Nowak HE; Gumułka SW; Mizerska K
    Life Sci; 1999; 65(4):395-402. PubMed ID: 10421425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid receptor subtype control of galanin-induced feeding.
    Barton C; York DA; Bray GA
    Peptides; 1996; 17(2):237-40. PubMed ID: 8801527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Jan; 782(1-2):18-23. PubMed ID: 9519245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa-opioid antagonist strongly attenuates drinking of genetically polydipsic mice.
    Katafuchi T; Hattori Y; Nagatomo I; Koizumi K
    Brain Res; 1991 Apr; 546(1):1-7. PubMed ID: 1649665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
    Baumann MH; Rabii J
    Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of beta-funaltrexamine on ingestive behaviors in the rat.
    Ukai M; Holtzman SG
    Eur J Pharmacol; 1988 Aug; 153(2-3):161-5. PubMed ID: 2846315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
    Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
    Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats.
    Glass MJ; Hahn B; Joseph A; Bodnar RJ
    Brain Res; 1994 Sep; 657(1-2):310-4. PubMed ID: 7820634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
    Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of opioid compounds on feeding and activity of the cockroach, Periplaneta americana.
    Cooper PD; Dennis SR; Woodman JD; Cowlings A; Donnelly C
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Apr; 151(3):298-302. PubMed ID: 20005975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
    Watkins LR; Wiertelak EP; Maier SF
    Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.